207 related articles for article (PubMed ID: 35661188)
1. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR; Alexdottir MS; Otten AT; Loveikyte R; Bay-Jensen AC; Pehrsson M; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Karsdal MA; Faber KN; Mortensen JH; Dijkstra G
Aliment Pharmacol Ther; 2022 Aug; 56(4):675-693. PubMed ID: 35661188
[TBL] [Abstract][Full Text] [Related]
2. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
3. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
4. Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Front Med (Lausanne); 2022; 9():933872. PubMed ID: 35903311
[TBL] [Abstract][Full Text] [Related]
5. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897710
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
[TBL] [Abstract][Full Text] [Related]
7. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.
Goffin L; Fagagnini S; Vicari A; Mamie C; Melhem H; Weder B; Lutz C; Lang S; Scharl M; Rogler G; Chvatchko Y; Hausmann M
Inflamm Bowel Dis; 2016 Sep; 22(9):2041-57. PubMed ID: 27542125
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn's Disease and Ulcerative Colitis.
Domislovic V; Høg Mortensen J; Lindholm M; Kaarsdal MA; Brinar M; Barisic A; Manon-Jensen T; Krznaric Z
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233775
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
[TBL] [Abstract][Full Text] [Related]
10. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.
Dobrota R; Jordan S; Juhl P; Maurer B; Wildi L; Bay-Jensen AC; Karsdal MA; Herrick AL; Distler JHW; Allanore Y; Hoffmann-Vold AM; Siebuhr AS; Distler O
Lancet Rheumatol; 2021 Mar; 3(3):e175-e184. PubMed ID: 38279380
[TBL] [Abstract][Full Text] [Related]
11. Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients.
Gudmann NS; Hirata S; Karsdal MA; Kubo S; Bay-Jensen AC; Tanaka Y
Clin Exp Rheumatol; 2018; 36(3):462-470. PubMed ID: 29465351
[TBL] [Abstract][Full Text] [Related]
12. Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study.
van Haaften WT; Mortensen JH; Dige AK; Grønbæk H; Hvas CL; Bay-Jensen AC; Karsdal MA; Olinga P; Manon-Jensen T; Dijkstra G
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00217. PubMed ID: 33094957
[TBL] [Abstract][Full Text] [Related]
13. The collagen turnover profile is altered in patients with inguinal and incisional hernia.
Henriksen NA; Mortensen JH; Sorensen LT; Bay-Jensen AC; Ågren MS; Jorgensen LN; Karsdal MA
Surgery; 2015 Feb; 157(2):312-21. PubMed ID: 25616945
[TBL] [Abstract][Full Text] [Related]
14. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
Lipton A; Leitzel K; Ali SM; Polimera HV; Nagabhairu V; Marks E; Richardson AE; Krecko L; Ali A; Koestler W; Esteva FJ; Leeming DJ; Karsdal MA; Willumsen N
Int J Cancer; 2018 Dec; 143(11):3027-3034. PubMed ID: 29923614
[TBL] [Abstract][Full Text] [Related]
15. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium Colitis.
Lindholm M; Manon-Jensen T; Madsen GI; Krag A; Karsdal MA; Kjeldsen J; Mortensen JH
Dig Dis Sci; 2019 Nov; 64(11):3134-3142. PubMed ID: 31123972
[TBL] [Abstract][Full Text] [Related]
17. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
Jessen H; Hoyer N; Prior TS; Frederiksen P; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
Respir Res; 2021 Jul; 22(1):205. PubMed ID: 34261485
[TBL] [Abstract][Full Text] [Related]
18. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.
Kehlet SN; Sanz-Pamplona R; Brix S; Leeming DJ; Karsdal MA; Moreno V
Sci Rep; 2016 Jul; 6():30599. PubMed ID: 27465284
[TBL] [Abstract][Full Text] [Related]
19. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
Wu J; Lubman DM; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC; Griffiths AM; Baldassano RN; Noe JD; Rabizadeh S; Gulati AS; Rosh JR; Crandall WV; Higgins PDR; Stidham RW
Am J Gastroenterol; 2019 May; 114(5):777-785. PubMed ID: 31058681
[TBL] [Abstract][Full Text] [Related]
20. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
